Index
RUT
Market Cap
419.16M
Enterprise Value
208.77M
Income
63.89M
Sales
412.49M
Book/sh
5.81
Cash/sh
4.47
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
191
IPO
May 13, 2010
P/E
8.01
Forward P/E
-
PEG
-
P/S
1.02
P/B
0.91
P/C
1.18
P/FCF
1.36
EV/EBITDA
1.04
EV/Sales
0.51
Quick Ratio
2.22
Current Ratio
2.43
Debt/Eq
0.31
LT Debt/Eq
0.31
Option/Short
Yes / Yes
EPS (ttm)
0.66
EPS next Y
-0.05
EPS next Q
-0.15
EPS this Y
-79.12%
EPS next Y
-112.68%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
1582.83% 319.75%
EPS Y/Y TTM
-64.25%
Sales Y/Y TTM
92.48%
EPS Q/Q
-114.91%
Sales Q/Q
-47.72%
Insider Own
8.29%
Insider Trans
1.88%
Inst Own
59.72%
Inst Trans
4.71%
ROA
7.66%
ROE
15.29%
ROIC
10.52%
Gross Margin
77.47%
Oper. Margin
38.56%
Profit Margin
15.49%
SMA20
-8.04%
SMA50
-23.12%
SMA200
-29.66%
Trades
Shs Outstand
79.48M
Shs Float
72.94M
52W High
13.02 -59.52%
52W Low
4.47 18.03%
Volatility
8.62% 8.64%
ATR (14)
0.42
RSI (14)
40.39
Beta
1.50
Rel Volume
2.58
Avg Volume
1.40M
Volume
3,609,738
Perf Week
13.09%
Perf Month
-34.94%
Perf Quarter
-36.35%
Perf Half Y
-33.96%
Perf YTD
-54.69%
Perf Year
-45.78%
Perf 3Y
39.42%
Perf 5Y
2.73%
Perf 10Y
-42.72%
Prev Close
5.08
Price
5.27
Change %
3.74%
Analysts 13 incl. previous ratings
Rating Distribution 13 Buy · 0 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 23, 2026 Initiated O Oppenheimer
Outperform $15 +184.6% Oct 20, 2025 Upgrade D D. Boral Capital
Hold → Buy $14 +165.7% Jun 30, 2025 Initiated H H.C. Wainwright
Buy $20 +279.5% Jun 30, 2025 Downgrade D D. Boral Capital
Buy → Hold Mar 07, 2025 Initiated L Leerink Partners
Outperform $18 +241.6% Jan 13, 2025 Initiated D D. Boral Capital
Buy $15 +184.6% Aug 26, 2024 Initiated R Rodman & Renshaw
Buy $13 +146.7% Aug 10, 2023 Initiated R RBC Capital Mkts
Outperform $6 +13.9% Feb 17, 2021 Initiated N Needham
Buy $31 +488.2% Sep 29, 2020 Initiated J JMP Securities
Mkt Outperform $22 +317.5% Sep 21, 2020 Initiated T Truist
Buy $20 +279.5% Dec 18, 2019 Initiated B B. Riley FBR
Buy $48 +810.8% Mar 26, 2019 Reiterated H H.C. Wainwright
Buy $3 → $15 +184.6% Dec 06, 2018 Initiated R ROTH Capital
Buy $6 +13.9% Sep 25, 2017 Reiterated H H.C. Wainwright
Buy $3 → $4 -24.1% Aug 10, 2017 Reiterated R Rodman & Renshaw
Buy $5 → $3 -43.1% May 05, 2017 Reiterated R Rodman & Renshaw
Buy $6 → $5 -5.1% Nov 11, 2016 Reiterated F FBR & Co.
Outperform $6 → $4 -24.1% Mar 17, 2016 Reiterated F FBR Capital
Outperform $7 → $6 +13.9% Mar 03, 2016 Initiated F FBR Capital
Outperform $7 +32.8%
Show Previous Ratings
Nov-16-26 09:04AM
Nov-12-26 10:47AM
(Earnings Whispers)
-8.68%
07:43AM
07:30AM
Nov-09-26 08:59AM
07:00AM
Loading…
07:00AM
Nov-06-26 08:30AM
Nov-04-26 03:50PM
Nov-02-26 08:39AM
07:30AM
Oct-30-26 03:51PM
Oct-19-26 07:30AM
Oct-15-26 07:30AM
Sep-01-26 08:30AM
Aug-13-26 07:08PM
(GuruFocus.com)
+14.65%
-7.37%
11:04AM
Loading…
11:04AM
07:40AM
07:30AM
Jul-29-26 08:30AM
Jun-08-26 08:30AM
May-15-26 08:30AM
May-14-26 07:02PM
10:06AM
07:37AM
07:30AM
May-05-26 08:30AM
Apr-27-26 07:30AM
Apr-07-26 08:30AM
Mar-05-26 08:18PM
04:04PM
08:50AM
Loading…
08:50AM
07:56AM
(Associated Press Finance)
07:30AM
Mar-02-26 08:30AM
Feb-27-26 08:05AM
Feb-26-26 08:05PM
Feb-24-26 08:02AM
Feb-23-26 10:45AM
Feb-17-26 10:30AM
Feb-12-26 08:30AM
Feb-11-26 03:16PM
08:01AM
Feb-10-26 06:19PM
Feb-02-26 08:30AM
Jan-31-26 07:57AM
Jan-30-26 08:39AM
Jan-29-26 08:30AM
Jan-23-26 10:59AM
Jan-20-26 09:38AM
Jan-19-26 11:28AM
Jan-15-26 08:38AM
Jan-12-26 02:07PM
11:20AM
10:14AM
10:08AM
09:33AM
09:32AM
Jan-09-26 11:46AM
09:40AM
09:17AM
08:30AM
Jan-08-26 12:33PM
12:21PM
11:09AM
09:44AM
08:50AM
08:05AM
08:00AM
Jan-07-26 12:31PM
11:52AM
11:49AM
11:45AM
09:53AM
Jan-06-26 11:53AM
11:47AM
11:18AM
10:19AM
Jan-05-26 10:58AM
10:28AM
10:26AM
Jan-02-26 11:22AM
10:54AM
10:22AM
08:15AM
Dec-31-25 02:42PM
11:24AM
09:50AM
07:36AM
Dec-30-25 11:00AM
07:58AM
Dec-29-25 09:53AM
09:50AM
Dec-26-25 09:12AM
Dec-24-25 11:22AM
11:05AM
09:59AM
Dec-23-25 03:20PM
10:45AM
10:35AM
10:21AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blum Susan Chief Financial Officer Nov 19 '26 Buy 4.58 5,000 22,900 129,315 Nov 20 05:00 PM Lefkowitz Steven W Director Nov 18 '26 Buy 4.53 11,500 52,095 137,451 Nov 20 01:34 PM Kaplan Myron Director Nov 16 '26 Buy 4.88 25,000 122,000 256,487 Nov 18 05:21 PM Todisco Joseph Chief Executive Officer Nov 13 '26 Buy 4.89 80,000 391,200 854,749 Nov 16 07:30 AM Dillione Janet Director Jan 21 '26 Sale 6.88 10,000 68,800 38,473 Jan 22 09:30 PM Janet Dillione Director Jan 21 '26 Proposed Sale 6.85 10,000 68,502 Jan 21 04:42 PM Todisco Joseph Chief Executive Officer Jan 16 '26 Option Exercise 3.38 29,585 99,997 521,664 Jan 20 09:28 AM Lefkowitz Steven W Director Jan 12 '26 Option Exercise 5.63 15,000 84,450 95,498 Jan 14 09:30 PM DUNTON ALAN W Director Dec 30 '25 Option Exercise 4.03 20,000 80,600 60,250 Jan 02 09:30 PM DUNTON ALAN W Director Dec 30 '25 Sale 13.00 20,000 260,000 40,250 Jan 02 09:30 PM Alan Dunton Director Dec 30 '25 Proposed Sale 12.97 20,000 259,400 Dec 30 04:28 PM Todisco Joseph Chief Executive Officer Dec 18 '25 Option Exercise 4.43 30,000 132,900 539,496 Dec 19 09:30 PM Todisco Joseph Chief Executive Officer Dec 18 '25 Sale 12.00 30,000 360,000 509,496 Dec 19 09:30 PM Joseph Todisco Officer Dec 18 '25 Proposed Sale 11.97 30,000 359,149 Dec 18 04:35 PM Dillione Janet Director Dec 09 '25 Option Exercise 7.82 34,000 265,900 82,473 Dec 11 08:38 AM Dillione Janet Director Dec 09 '25 Sale 12.00 34,000 408,000 48,473 Dec 11 08:38 AM Lefkowitz Steven W Director Dec 09 '25 Sale 11.88 40,000 475,200 80,498 Dec 10 09:38 PM Janet Dillione BOD Dec 09 '25 Proposed Sale 12.00 34,000 408,000 Dec 09 04:43 PM Lefkowitz Steven W Director Dec 09 '25 Proposed Sale 11.26 40,000 450,400 Dec 09 04:27 PM Dillione Janet Director Dec 02 '25 Option Exercise 3.96 46,657 184,802 95,130 Dec 04 09:30 PM Dillione Janet Director Dec 02 '25 Sale 10.00 46,657 466,570 48,473 Dec 04 09:30 PM Dillione Janet Director Nov 24 '25 Option Exercise 3.64 26,343 95,948 74,816 Nov 26 09:30 PM Dillione Janet Director Nov 24 '25 Sale 9.93 26,343 261,586 48,473 Nov 26 09:30 PM Janet Dillione Director Nov 24 '25 Proposed Sale 9.97 73,000 727,927 Nov 24 04:14 PM
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
CEO & Chairman of the Board of Directors Mr. Joseph Todisco MBA
Executive VP and Chief Operating & Commercial Officer Ms. Elizabeth Masson-Hurlburt B.A.
EVP Ms. Kaufman Beth Zelnick Esq.
EVP & Chief Financial Officer Ms. Susan Blum
SVP & Chief Human Resource Officer Ms. Beth Steinbrenner